Prostaglandin E2 Receptors as Potential Bone Anabolic Targets – Selective EP4 Receptor Agonists

E-ISSN： 1874-4702|5|2|174-181

ISSN： 1874-4672

Source： Current Molecular Pharmacology, Vol.5, Iss.2, 2012-01, pp. : 174-181

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prostaglandin E 2 increases surfactant secretion via the EP 1 receptor in rat alveolar type II cells

By Morsy M.A.M. Isohama Y. Miyata T.

European Journal of Pharmacology, Vol. 426, Iss. 1, 2001-08 ,pp. : 21-24

Elsevier

Access to resources Recommend Favorite

Prostaglandin EP 4 antagonists

By Borriello Manuela Stasi Luigi Piero

Pharmaceutical Patent Analyst, Vol. 2, Iss. 3, 2013-05 ,pp. : 387-397

Future Science

Access to resources Recommend Favorite

Serotonin Type-4 (5-HT4) Receptors as Therapeutic Targets: Past and Future Roles of 5-HT4 Receptor Agonists

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 3, Iss. 1, 2003-03 ,pp. : 27-36

Bentham Science Publishers

Access to resources Recommend Favorite

CD14-Dependent Innate Immunity-Mediated Neuronal Damage in Vivo is Suppressed by NSAIDs and Ablation of a Prostaglandin E2 Receptor, EP2

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 5, Iss. 2, 2005-06 ,pp. : 151-156

Bentham Science Publishers

Access to resources Recommend Favorite

Regulatory Mechanism of the Gastric Hyperemic Response Following Barrier Disruption: Roles of Cyclooxygenase-1, the Prostaglandin E2/EP1 Receptor and Sensory Neurons

Current Pharmaceutical Design, Vol. 21, Iss. 21, 2015-06 ,pp. : 3002-3011

Bentham Science Publishers

Access to resources Recommend Favorite